Pubblicazioni

Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis

2022 - MULTIPLE SCLEROSIS AND RELATED DISORDERS

Zappulo, Emanuela; Buonomo, Antonio Riccardo; Moccia, Marcello; Pinchera, Biagio; Villari, Riccardo; Petracca, Maria; Lanzillo, Roberta; Scotto, Riccardo; Carotenuto, Antonio; Viceconte, Giulio; Schiano Moriello, Nicola; Bruno, Luca; Gentile, Ivan; Brescia Morra, Vincenzo

Alemtuzumab outcomes by age: Post hoc analysis from the randomized CARE-MS studies over 8 years

2020 - MULTIPLE SCLEROSIS AND RELATED DISORDERS

Bass, Ann D; Arroyo, Rafael; Boster, Aaron L; Boyko, Alexey N; Eichau, Sara; Ionete, Carolina; Limmroth, Volker; Navas, Carlos; Pelletier, Daniel; Pozzilli, Carlo; Ravenscroft, Jennifer; Sousa, Livia; TintorÃ©, Mar; Uitdehaag, Bernard M J; Baker, Darren P; Daizadeh, Nadia; Choudhry, Zia; Rog, David